Nathan Vandergrift

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Development and validation of a community-level social determinants of health index for drug overdose deaths in the HEALing Communities Study

Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study

Comorbid alcohol use disorder and post-traumatic stress disorder: A proof-of-concept randomized placebo-controlled trial of buprenorphine and naltrexone combination treatment

Performance of model-based vs. permutation tests in the HEALing (Helping to End Addiction Long-termSM) communities study, a covariate-constrained cluster randomized trial

Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument

Marginal modeling in community randomized trials with rare events: Utilization of the negative binomial regression model

The HEALing (Helping to End Addiction Long-term <sup>SM</sup>) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices

Co-immunization of DNA and protein in the same anatomical sites induces superior protective immune responses against SHIV challenge

Neonatal rhesus macaques have distinct immune cell transcriptional profiles following HIV envelope immunization

Development and performance of a hereditary hemorrhagic telangiectasia specific quality of life instrument

Intrahost dynamics of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees

Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys

RAB11FIP5 expression and altered natural killer cell function are associated with induction of HIV broadly neutralizing antibody responses

IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells

HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions

Immunogenicity of NYVAC prime-protein boost Human Immunodeficiency Virus type 1 envelope vaccination and Simian-Human Immunodeficiency Virus challenge of nonhuman primates

Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys

Computational analysis of antibody dynamics identifies recent HIV-1 infection

Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations

HIV DNA-adenovirus multiclade envelope vaccine induces gp41 antibody immunodominance in rhesus macaques